Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
Key Highlights
- ➤Lexicon (LXRX) will report third quarter 2026 results November 5 before market open
- ➤Management will discuss financial results and provide a business update at 8:30 a.m. ET
- ➤Lexicon is advancing programs in hypertrophic cardiomyopathy, type 1 diabetes and obesity
THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its third quarter 2026 financial results on Thursday, November 5, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update.
Participants can access the conference call live via webcast on the Events page of the Company’s website at https://investors.lexpharma.com/. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website.
Get started
Create a free account to read the full story.